Top news of the week: 17.11.2021.
Startups
The Billionaire Chairman Of Vaccine Maker Moderna Wants To Reinvent Scientific Entrepreneurship
Noubar Afeyan launched 70 companies by pushing researchers to ask what if their craziest ideas were true. With $17 billion and a model of “parallel entrepreneurship,” he can fund a lot of ...
Gerngross biotech Ankyra Therapeutics nabs $45M series B to jump into the clinic, hires new CMO
Little startup Ankyra has grabbed a relatively small $45 million B round as it plots getting its leading oncology hopeful into the clinic.
LabCentral Appoints Gretchen Cook-Anderson as Executive Director of LabCentral Ignite
/PRNewswire/ -- LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced it has...
The scientist who helped Moderna become a vaccine powerhouse tells us why he thinks gene editing is the future for the $91 billion biotech
Eric Huang told Insider how he planned to make Moderna Genomics a gene-editing leader by 2030. "Moderna doesn't move slowly," he said.
This Startup Raised $100 Million In Bid To Power All Doctor Information On The Internet
H1 cofounders Ariel Katz and Ian Sax have scraped global healthcare data into a LinkedIn-like interface to help biopharma companies figure out the best doctor to involve in a clinical trial ...
Our Founders
Genentech was founded in 1976 late venture capitalist Robert A. Swanson the biochemist Dr. Herbert W. Boyer.
Janis Naeve, Amgen
From working on the first monoclonal antibodies as a Ph.D. student to investing in cell-based therapies in her current role, Amgen's Janis Naeve has seen the industry's tech come a long way.
Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment
Revive Therapeutics, a Toronto-based psychedelics, cannabinoid and infectious disease-focused biotech firm is currently in a late FDA Phase 3 trial for its oral treatment targeting ...